Start your intake Tirzepatide as a dual-incretin compound Where semaglutide, liraglutide, and dulaglutide engage the GLP-1 receptor alone, tirzepatide is a GIP/GLP-1 dual agonist it also activates the GIP receptor, adding a second incretin mechanism to appetite regulation, satiety signaling, and gastric emptying
Obesogens: a unifying theory for the global rise in obesity
Taken together, these findings suggest that combining GLP-1 and estrogen signaling does not simply add two neuroprotective effects together
Increase fluids and electrolytes
Of the 93 participants in our study, 11 patients (12%) discontinued treatment
This has impacted availability through legitimate medical channels